Pure Global
NCT06390683

Biodiversity Interventions for Assisted Living Centers

Biodiversity Interventions for Well-Being - Research in Assisted Living Centers
Natural Resources Institute Finland·ClinicalTrials.gov·otherRecruitment Completed
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Nature, Human,Microbial Colonization,Well-Being, Psychological,Immune System and Related Disorders,Autism Spectrum Disorder,Visual Impairment
Drug/Device/Intervention
Rewilding
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Natural Resources Institute Finland
Location
Helsinki, Finland
Timeline & enrollment
Phase
N/A
Start date
Feb 01, 2023
End date
Sep 30, 2027
Enrollment
36 participants
Primary outcome

Skin Gammaproteobacteria

Summary

Biodiversity is essential for nature and human well-being. Land use has reduced biodiversity
 in cities, which weakens the functionality of the urban ecosystems and the well-being of
 citizens. This may also increase the risk of immune-mediated disorders among urban dwellers.
 
 In Biodiversity interventions for assisted living centers (BIWE 2), microbial biodiversity
 interventions are performed to increase biodiversity in urban housing units for people with
 autism spectrum disorder, disabled people and elderly. Results from the intervention trials
 are combined with publicly available land cover and ecological data. These are analyzed from
 the viewpoint of shifts in ecosystems and human well-being and immune regulation, ecological
 quality, and urban planning.
 
 The investigators set up an intervention study in which yards of the housing units are
 rewilded with diverse vegetation and decaying deadwood and plant residuals. The investigators
 aim to evaluate the effect of rewilding, and yard management practices on commensal
 microbiome, cortisol levels and well-being and salivary cytokine levels, and gene pathways.

ICD-10 classifications
Other specified bacterial diseasesOther bacterial diseasesOther pervasive developmental disordersOther bacterial diseases, not elsewhere classifiedContact with and exposure to other communicable diseases
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06390683
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06390683 through Pure Global AI's free database. This phase not specified trial is sponsored by Natural Resources Institute Finland and is currently Recruitment Completed. The study focuses on Nature, Human,Microbial Colonization,Well-Being, Psychological,Immune System and Related Disorders,Autism Spectrum Disorder,Visual Impairment. Target enrollment is 36 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.